-
IntroducedJan 30, 2025
-
Passed Senate
-
Passed House
-
Signed into Law
REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.
Last Action See all actions
Senate • Mar 24, 2025: The committee on HHS deferred the measure.
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on SR 4
Tweets
Whip Lists
Sponsors
Votes
Actions
- Mar 24, 2025 | Senate
- The committee on HHS deferred the measure.
- Mar 20, 2025 | Senate
- The committee(s) on HHS has scheduled a public hearing on 03-24-25 1:05PM; Conference Room 225 & Videoconference.
- Feb 03, 2025 | Senate
- Referred to HHS, WAM.
- Jan 30, 2025 | Senate
- Offered.
Bill Texts
Documents